TENEBITE M 20/1000MG TABLET 15'S

Is it safe to use TENEBITE M 20/1000MG TABLET 15'S?

TENEBITE M 20/1000MG TABLET 15'S are safe and effective for treating type 2 diabetes. However, they come with potential risks and side effects such as gastrointestinal symptoms, lactic acidosis (METFORMIN), and rare cases of pancreatitis (Teneligliptin). Discuss with your doctor to determine if it's right for you.

Can the use of TENEBITE M 20/1000MG TABLET 15'S lead to hypoglycemia?

The use of TENEBITE M 20/1000MG TABLET 15'S is generally not associated with hypoglycemia (low blood sugar), as they work to lower blood sugar levels without promoting excessive insulin secretion. However, hypoglycemia can occur in certain circumstances, such as when taking these medications with other diabetes medications or skipping meals. It's important to monitor blood sugar levels and discuss any concerns with your doctor.

Can the use of TENEBITE M 20/1000MG TABLET 15'S cause nausea and vomiting?

Yes, the use of TENEBITE M 20/1000MG TABLET 15'S can cause nausea and vomiting as common side effects. These symptoms are usually mild and resolve on their own or with dose adjustments. If nausea and vomiting are persistent or severe, it's important to discuss with your doctor to determine the best course of action.

Are there any specific contraindications associated with the use of TENEBITE M 20/1000MG TABLET 15'S?

The use of TENEBITE M 20/1000MG TABLET 15'S is contraindicated in patients with a history of hypersensitivity to either medication. METFORMIN is also contraindicated in patients with severe kidney or liver disease, dehydration, or who are at risk for lactic acidosis. Teneligliptin is contraindicated in patients with type 1 diabetes or diabetic ketoacidosis. It's important to discuss any medical history with your doctor before taking these medications.

Can the use of TENEBITE M 20/1000MG TABLET 15'S cause lactic acidosis?

METFORMIN has a rare but serious side effect called lactic acidosis, which occurs when there is an accumulation of lactic acid in the blood. While Teneligliptin is not associated with lactic acidosis, the risk may be increased when it is used in combination with METFORMIN, especially in patients with kidney or liver problems. However, the overall risk of lactic acidosis with TENEBITE M 20/1000MG TABLET 15'S is low when used as directed and monitored appropriately. It's important to discuss any concerns with your doctor.

Can the use of TENEBITE M 20/1000MG TABLET 15'S lead to Vitamin B12 deficiency?

There is some evidence to suggest that long-term use of METFORMIN may lead to a decreased absorption of vitamin B12 in the body, which could potentially lead to deficiency. However, there is no evidence to suggest that Teneligliptin has any effect on vitamin B12 levels. Patients taking TENEBITE M 20/1000MG TABLET 15'S should have their vitamin B12 levels monitored regularly and consider taking a supplement if necessary. It's important to discuss any concerns with your doctor.

What is the storage condition for the TENEBITE M 20/1000MG TABLET 15'S?

TENEBITE M 20/1000MG TABLET 15'S should be stored at room temperature, away from moisture and heat. It should be kept in the original container, with the lid tightly closed, and out of reach of children and pets. The medication should not be stored in the bathroom or near the kitchen sink, where it could be exposed to moisture. It's important to follow the storage instructions on the label and to discard any expired or unused medication properly.

What is Tenebite M 20/1000 Tablet used for?

Tenebite M 20/1000 Tablet is prescribed for managing Type 2 diabetes. It helps improve blood sugar control in patients who do not achieve adequate results with Metformin alone.

What are the side effects of Tenebite M 20/1000 Tablet?

Tenebite M 20/1000 Tablet may cause side effects such as nausea, vomiting, diarrhea, headache, stomach pain, respiratory infections, weight gain, sweating, palpitations, and vision problems. If any of these side effects persist or worsen, consult your doctor for further guidance.